Weight loss drugs are everywhere and recently Zepbound (tirzepitide) made big news when it became the first FDA-approved sleep apnea therapy for mild to moderate sleep apnea. In this episode, we will:

• Introduce and explain weight loss medications
• Review the studies that convinced the FDA to approve Zepbound for sleep apnea
• Provide an overview on this class of weight loss medications
• Evaluate the risks and determine who is a best match for this therapy
• Touch on the cost and difficulty in getting these drugs approved
• Revisit Apnimed's SynAIRgy press release and how it relates to our discussion in episode 110 of the podcast

Produced by: Maeve Winter

More

• Twitter: @drchriswinter
• IG: @drchriwinter
• Threads: @drchriswinter
• Bluesky: @drchriswinter
• The Sleep Solution and The Rested Child

Thanks for listening and sleep well!